Exploring Current Clinical Perspectives On Targeted Therapy And Immunotherapy For Melanoma
Exploring Current Clinical Perspectives On Targeted Therapy And Immunotherapy For Melanoma reveals several interesting facts.
- Adil Daud, MD, a
- At the 2015 American Society of
- Michael Atkins, MD, FASCO, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, provides the background ...
- Dr. Gino K. In, MD, MPH, Associate Professor of Medicine at USC Norris Comprehensive Cancer Center, for an exclusive ...
- Richard Carvajal, MD, Director of Experimental Therapeutics and Director of the
In-Depth Information on Current Clinical Perspectives On Targeted Therapy And Immunotherapy For Melanoma
At the 2015 American Society of At the 2015 American Society of Panelists Robert H.I. Andtbacka, MD, CM; Michael A. Postow, MD; and Michael A. Davies, MD, PhD, outline patient selection ... Join Dr. Vince Ma,
Igor Puzanov, MD, director, Early Phase
Stay tuned for more updates related to Current Clinical Perspectives On Targeted Therapy And Immunotherapy For Melanoma.
